Data / Form D filings / IB Pharmaceuticals Inc.
IB Pharmaceuticals Inc.: Form D filings
IB Pharmaceuticals Inc., a pharmaceuticals company in Raleigh, NC, filed 6 Form D notices with the SEC between 2016 and 2018. The latest, on February 12, 2018, reports $32.8 million sold of a $36.3 million offering to 168 investors.
Find out what IB Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8480 HONEYCUTT ROAD, SUITE 120, Raleigh, NC, 27615
- Phone
- (919) 275-1933
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1666690
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2018 | New notice | $36,316,200 | $32,751,768 | $3,564,432 | 168 | Jan 29, 2018 | sec.gov |
| Feb 12, 2018 | New notice | $4,800,000 | $4,800,000 | $0 | 1 | Jan 29, 2018 | sec.gov |
| Dec 4, 2017 | New notice | $2,000,000 | $1,450,000 | $550,000 | 13 | Sep 28, 2017 | sec.gov |
| May 11, 2017 | New notice | $5,000,000 | $1,000,000 | $4,000,000 | 1 | Apr 27, 2017 | sec.gov |
| Nov 9, 2016 | Amendment | $10,000,000 | $2,651,600 | $7,348,400 | 19 | Jan 22, 2016 | sec.gov |
| Feb 11, 2016 | New notice | $5,925,000 | $1,448,538 | $4,476,462 | 12 | Jan 22, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jay Madan | Executive Officer, Director | |
| Christopher Prior | Executive Officer | |
| Sandeep Laumas | Executive Officer, Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Feb 12, 2018 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what IB Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.